Detection of local recurrence of soft-tissue sarcoma with positron emission tomography using [F-18] fluorodeoxyglucose

被引:71
|
作者
Kole, AC
Nieweg, OE
vanGinkel, RJ
Pruim, J
Hoekstra, HJ
Paans, AMJ
Vaalburg, W
Koops, HS
机构
[1] UNIV GRONINGEN HOSP,DEPT SURG ONCOL,NL-9700 RB GRONINGEN,NETHERLANDS
[2] UNIV GRONINGEN HOSP,PET CTR,NL-9700 RB GRONINGEN,NETHERLANDS
[3] NETHERLANDS CANC INST,DEPT SURG,AMSTERDAM,NETHERLANDS
关键词
positron emission tomography; sarcoma; fluorodeoxyglucose; detection; recurrence;
D O I
10.1007/BF02316811
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: It is often difficult to detect a local recurrence of soft-tissue sarcomas due to disturbance of the normal anatomy by previous surgery and radiotherapy. The aim of this study was to assess the value of positron emission tomography (PET) with [F-18]fluoro3-deoxy-D-glucose (FDG) for detecting local recurrences. Methods: In the period 1992-1995, 17 patients with proven or suspected local recurrence of soft-tissue sarcoma were examined using FDG-PET. Fifteen of these patients were ultimately proven to have a recurrence. Results: Recurrence was visualized in 14 patients (93%). Small tumors (maximum diameter 0.5 cm) were as easily visible as large lesions (maximum diameter 20 cm). In one patient the PET scan was positive, but the recurrence could not be proven histologically. Recurrence was proven 1 year later. A recurrent low-grade liposarcoma was not visualized. The two patients with benign lesions had a negative PET scan. The mean glucose metabolic rate was calculated to be 13.2 mu mol/100 g/min (range 1.9-28.4). A correlation was found between the histological malignancy grade and the metabolic rate (p < 0.05; Kruskal-Wallis). Conclusion: PET with FDG is a useful addition to the diagnostic armamentarium for detecting local recurrence of soft-tissue sarcomas and provides an indication of the malignancy grade of the recurrent lesion.
引用
收藏
页码:57 / 63
页数:7
相关论文
共 50 条
  • [1] Detection of local recurrence of soft-tissue sarcoma with positron emission tomography using [18F]fluorodeoxyglucose
    Annemieke C. Kole
    Omgo E. Nieweg
    Robert J. van Ginkel
    Jan Pruim
    Harald J. Hoekstra
    Anne M. J. Paans
    Willem Vaalburg
    Heimen Schraffordt Koops
    Annals of Surgical Oncology, 1997, 4 : 57 - 63
  • [2] 18F-Fluorodeoxyglucose positron emission tomography/computed tomography for the detection of recurrent bone and soft tissue sarcoma
    Al-Ibraheem, Akram
    Buck, Andreas K.
    Benz, Matthias R.
    Rudert, Maximilian
    Beer, Ambros J.
    Mansour, Asem
    Pomykala, Kelsey L.
    Haller, Bernhard
    Juenger, Hendrik
    Scheidhauer, Klemens
    Schwaiger, Markus
    Herrmann, Ken
    CANCER, 2013, 119 (06) : 1227 - 1234
  • [3] Role of F-18 fluorodeoxyglucose positron emission tomography/computed tomography in the detection of recurrence in patients with cervical cancer
    Bhoil, Amit
    Mittal, Bhagwant Rai
    Bhattacharya, Anish
    Santhosh, Sampath
    Patel, Firuza
    INDIAN JOURNAL OF NUCLEAR MEDICINE, 2013, 28 (04): : 216 - 220
  • [4] F-18 Fluorodeoxyglucose Positron Emission Tomography in a Transitional Meningioma
    Amemiya, Shiori
    Aoki, Shigeki
    Akahane, Masaaki
    Ohtomo, Kuni
    CLINICAL NUCLEAR MEDICINE, 2009, 34 (07) : 462 - 463
  • [5] F-18 fluorodeoxyglucose positron emission tomography in testicular cancer
    Gumuser, Gul
    Aras, Feray
    Bilgin, Elvan Sayit
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2012, 11 (03): : 193 - 195
  • [6] Postsurgical Atypical F-18 Fluorodeoxyglucose Positron Emission Tomography Uptake
    Dubroff, Jacob G.
    Alavi, Abass
    Friedberg, Joseph S.
    Cengel, Keith A.
    CLINICAL NUCLEAR MEDICINE, 2009, 34 (11) : 808 - 810
  • [7] POSITRON EMISSION TOMOGRAPHY - ROLE OF F-18 FLUORODEOXYGLUCOSE ((18)FDG) IMAGING IN ONCOLOGY
    LAGRANGE, JL
    MAUBLANT, J
    DARCOURT, J
    BULLETIN DU CANCER, 1995, 82 (08) : 611 - 622
  • [8] F-18 fluorodeoxyglucose positron emission tomography in the diagnosis of inflammatory bowel disease
    Kresnik, E
    Mikosch, P
    Gallowitsch, HJ
    Heinisch, M
    Lind, P
    CLINICAL NUCLEAR MEDICINE, 2001, 26 (10) : 867 - 867
  • [9] F-18 fluorodeoxyglucose positron emission tomography in mesenterial Castleman's lymphoma
    Kunishima, S
    Taniguchi, H
    Koh, T
    Yamaguchi, A
    Yamagishi, H
    CLINICAL NUCLEAR MEDICINE, 2001, 26 (09) : 789 - 790
  • [10] POSITRON EMISSION TOMOGRAPHY WITH FLUORINE-18-FLUORODEOXYGLUCOSE FOR THE EVALUATION OF THERAPEUTIC ISOLATED REGIONAL LIMB PERFUSION IN A PATIENT WITH SOFT-TISSUE SARCOMA
    NIEWEG, OE
    PRUIM, J
    HOEKSTRA, HJ
    PAANS, AMJ
    VAALBURG, W
    OLDHOFF, J
    KOOPS, HS
    JOURNAL OF NUCLEAR MEDICINE, 1994, 35 (01) : 90 - 92